Skip to content

A Diagnostic Nomogram for Predicting Vaginal Invasion in Cervical Cancer

Establish a New Noninvasive Diagnostic Model Based on Clinical Indicators to Evaluate the Vaginal Invasion in Cervical Cancer Patients

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06039982
Enrollment
100
Registered
2023-09-15
Start date
2023-11-01
Completion date
2026-11-01
Last updated
2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervix Carcinoma

Brief summary

This study aims to develop a diagnostic nomogram based on clinical factors with the prediction values of vaginal invasion in cervical cancer to optimize the treatment plan and surgical procedures.

Detailed description

Vaginal invasion is a crucial index participant in cervical cancer tumor staging and prognosis prediction. However, the roles of vaginal invasion are overlooked in the literature, compared with those of lymph node metastasis and parametrial invasion. As far as we know, this study is novel to construct a nomogram to predict the probability of pathologic vaginal invasion occurrence.

Interventions

OTHERno intervention

no intervention

Sponsors

Fujian Cancer Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Pathologically confirmed cervical cancer; * FIGO2018 stage IB-IIA according to the result of physical examination and images; * No preoperative treatment before surgery; * Abdominal MRI is performed within three weeks before surgery. Blood routine, biochemistry, blood tumor markers and coagulation function were examined within 1 week before surgery. * All patients undergo radical hysterectomy (RH) with bilateral pelvic lymphadenectomy or paraaortic lymph node dissection.

Exclusion criteria

* Accompanied with other tumors; * Accompanied with chronic infectious and immune diseases; * Incomplete clinical data.

Design outcomes

Primary

MeasureTime frameDescription
vaginal invasion7 days after surgery100 cervical cancer patients who underwent radical hysterectomy (RH) with bilateral pelvic lymphadenectomy were pathologically assessed for vaginal invasion. The primary outcome is vaginal invasion or no-vaginal invasion. Pathological vaginal invasion is defined as cervix tumor disruption of the vaginal wall.

Countries

China

Contacts

Primary ContactYang Sun, PHD
sunyang@fjzlhospital.com+8615959028989

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026